Your browser doesn't support javascript.
loading
Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.
Zanchetta, M B; Boailchuk, J; Massari, F; Silveira, F; Bogado, C; Zanchetta, J R.
Affiliation
  • Zanchetta MB; IDIM, Instituto de Diagnóstico e Investigaciones Metabólicas, Libertad 836, (P.C:1012), Buenos Aires, Argentina. mbzanchetta@idim.com.ar.
  • Boailchuk J; Cátedra de Osteología y Metabolismo Mineral, Universidad del Salvador, Buenos Aires, Argentina. mbzanchetta@idim.com.ar.
  • Massari F; IDIM, Instituto de Diagnóstico e Investigaciones Metabólicas, Libertad 836, (P.C:1012), Buenos Aires, Argentina.
  • Silveira F; IDIM, Instituto de Diagnóstico e Investigaciones Metabólicas, Libertad 836, (P.C:1012), Buenos Aires, Argentina.
  • Bogado C; Cátedra de Osteología y Metabolismo Mineral, Universidad del Salvador, Buenos Aires, Argentina.
  • Zanchetta JR; IDIM, Instituto de Diagnóstico e Investigaciones Metabólicas, Libertad 836, (P.C:1012), Buenos Aires, Argentina.
Osteoporos Int ; 29(1): 41-47, 2018 01.
Article in En | MEDLINE | ID: mdl-28975362

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Withholding Treatment / Bone Density Conservation Agents / Denosumab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Withholding Treatment / Bone Density Conservation Agents / Denosumab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2018 Document type: Article Affiliation country: Country of publication: